Hydrochloric Acid → 2-(4-Fluorophenyl)-3-(pyridin-4-yl)pyrazolo[1,5-a]pyrimidine

HRID 54938

Reaktionsgleichung

Reaktionsgleichung von HRID 54938
[NH2:1][C:2]1[NH:6][N:5]=[C:4]([C:7]2[CH:12]=[CH:11][C:10]([F:13])=[CH:9][CH:8]=2)[C:3]=1[C:14]1[CH:19]=[CH:18][N:17]=[CH:16][CH:15]=1.Cl.CO[CH:23](OC)[CH2:24][CH:25](OC)OC.C(=O)(O)[O-].[Na+]>C(O)C.[Cl-].[Zn+2].[Cl-]>[F:13][C:10]1[CH:11]=[CH:12][C:7]([C:4]2[C:3]([C:14]3[CH:19]=[CH:18][N:17]=[CH:16][CH:15]=3)=[C:2]3[N:1]=[CH:23][CH:24]=[CH:25][N:6]3[N:5]=2)=[CH:8][CH:9]=1

Komponenten

7

Versuchsvorschrift

To a solution of 5-amino-3-(4-fluorophenyl)-4-(pyridin-4-yl)pyrazole (102 mg) in ethanol (3 ml) were added concentrated hydrochloric acid (50 μl ), zinc chloride (27 mg) and 1,1,3,3-tetramethoxypropane (72 mg) in that order. The mixture was refluxed for one hour, cooled, and poured into an aqueous saturated sodium bicarbonate solution. The separated oil was extracted with dichloromethane. The extract was washed with brine, dried and concentrated in vacuo. The residue was crystallized from a mixture of ethyl acetate and diethyl ether to yield 2-(4-fluorophenyl)-3-(pyridin-4-yl)pyrazolo[1,5-a]pyrimidine (102 mg).

Aufarbeitung

  1. temperatureThe mixture was refluxed for one hour
  2. temperaturecooled
  3. extractionThe separated oil was extracted with dichloromethane
  4. washThe extract was washed with brine
  5. customdried
  6. concentrationconcentrated in vacuo
  7. customThe residue was crystallized from a mixture of ethyl acetate and diethyl ether

Quellen und Nachweise

ORD-Eintrag
ord-ae2a07aaacbc4495a74969ee0c2cc6ff
Quelldatensatz
uspto-grants-1997_04
Patentnummer
US05624931

Verknüpfte Notizen

Wird geladen…